Notably, since SF3B1 is also a trans-acting splicing factor for the BCL-XL/BCL-XS as shown in HeLa cells [33], meayamycin B did not significantly increase BCL-XS in lung cancer cells [34]. Here, BCL2L1 is linked to lung cancer.